Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 FY- Text added to 2022 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
back, began, biotech, bleeding, borrowing, broader, CJEU, Clarifying, disability, domain, endemic, ERC, evidenced, exploitation, Fargo, FDIC, forecast, gamma, geopolitical, glycan, hematologic, hepatocellular, IFN, Immunome, implicit, incremental, IRA, IRC, Justice, lessor, lump, macroeconomic, mislocalized, morale, Morgan, newly, nonqualified, nonrecurring, outpace, pembrolizumab, penalize, pharma, plasma, predominant, predominantly, primate, quantitative, refundable, reorganization, repriced, repricing, reside, residual, retrospective, sequestered, settlement, Silicon, situation, SVB, tiered, trajectory, undertook, unvested, Valley, vast, ZymeLink
Removed:
categorization, close, confidence, consult, cumulative, exit, formed, hierarchy, instrument, intercompany, legacy, LLP, lowest, mitigated, NOL, noted, occupied, occupy, orderly, OUM, owed, pattern, pertained, Pte, reach, resignation, reverse, ruling, secured, software, split, titled, transfer, unadjusted, unobservable, urge, validated, wholly
Valuein 2021 FY filing- Value in 2022 FY filing
Original filings
Filing view